A Meta-analysis of the Risk of Adverse Cardiovascular Events in Patients with Cancer Treated with Inhibitors of the PI3K/AKT/mTOR Signaling Pathway
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
No abstract available